Pfizer 2014 Annual Report Download - page 68

Download and view the complete annual report

Please find page 68 of the 2014 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 68
ANNUAL REVIEW 2014
Our World > Patient Engagement
PATIENT ENGAGEMENT
PATIENTS AT THE CENTER
People today are able to access and exchange more information than ever before,
and it’s no surprise that health is an area where information-sharing is exploding.
As patients become more informed, they become more involved — more active in
their own care and the care of others, and in medical research.
This is the era of “patient-centricity,” where patients are far from
passive subjects of study or treatment. Laypeople are taking starring
roles in designing clinical trials; tracking and managing their personal
health data; and, crowdsourcing new insights and solutions with
diverse, far-reaching communities.
What does “patient-centricity” mean for Pzer? “We’re sharing
information with patients in ways that are more relevant for them
— and importantly, we’re also listening to them and working to act
on what we hear,” answers Roslyn Schneider, M.D., Pzer’s Global
Patient Affairs lead.
“Pzer has always been ‘patient-centric’
in the sense of operating with patients as
the heart of our focus, but now more
often we’re offering patients a seat at the
table — literally.”
ROSLYN (ROZ) F.
SCHNEIDER
SENIOR DIRECTOR
GLOBAL PATIENT AFFAIRS
The KIDS (Kids and Families Impacting Disease through Science)
program invites children, adolescents and families into the research
process by allowing them to serve as an advisory group to improve
clinical studies for children and areas where more research is
needed. KIDS, a collaboration between the American Academy of
Pediatrics, children’s hospitals, local schools and other partners,
including Pzer, was piloted in 2013 in Connecticut and is expanding
to other U.S. locations and abroad. Projects have included input on
pediatric assent, feedback to industry researchers and formulators,
collaboration with undergraduate research students, and attendance
at international pediatric conferences.
KIDS (KIDS AND FAMILIES
IMPACTING DISEASE THROUGH SCIENCE)
Members of the KIDS Connecticut team at the Pediatric
Academic Societies Meeting in Vancouver in May 2014